During the past decade, Peel Memorial Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Peel Memorial Hospital" are "Obesity Associated With Defects in Leptin-melanocortin Pathway" (1 trials), "Ovarian Cancer" (1 trials) and "Pro-opiomelanocortin (POMC) Deficiency Obesity" (1 trials). Many other conditions were trialed in "Peel Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Peel Memorial Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Setmelanotide" (2 trials), "ISIS 5132" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peel Memorial Hospital" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Peel Memorial Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Peel Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peel Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".